Nrxs stock price.

Find the latest NRx Pharmaceuticals, Inc. (NRXP) stock quote, history, news and other vital information to help you with your stock trading and investing.Get a real-time NeurAxis, Inc. (NRXS) stock price quote with breaking news, financials, statistics, charts and more.Price vs Fair Value. View History. RPD is trading at a 25% premium. Price. $56.05. Dec 1, 2023. Fair Value. $86.00.The consensus price target of analysts on Wall Street is $9.50, which implies an increase of 35.05% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $7.00 and $11.00 respectively. As a result, EXAI is trading at a discount of -78.28% off the target high and -13.45% off the low.Dec 1, 2023 · 2 Wall Street analysts have issued 1-year target prices for NRx Pharmaceuticals' stock. Their NRXP share price targets range from $2.00 to $2.00. On average, they predict the company's share price to reach $2.00 in the next year. This suggests a possible upside of 537.3% from the stock's current price. View analysts price targets for NRXP or ...

Despite a brief intra-day dip below its $6 IPO price, shares continue to score bullish interest, closing at or higher than their opening day level in each of its trading sessions. Shares ripped over 10% higher last Friday on the heels of an analyst report from Goldman Smallcap Research that models NRXS shares reaching $14 in the next six to ...

View the latest Neuraxis Inc. (NRXS) stock price, news, historical charts, analyst ratings and financial information from WSJ.

The consensus price target of analysts on Wall Street is $3.08, which implies an increase of 87.99% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $2.00 and $5.25 respectively. As a result, NRXP is trading at a discount of -1318.92% off the target high and -440.54% off the low.Nov 27, 2023 · See the latest Neuraxis Inc stock price (NRXS:XASE), related news, valuation, dividends and more to help you make your investing decisions. Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools. Identify stocks that meet your criteria using seven unique stock screeners.Highlights November 1 – acquired a 336,448 square foot industrial property located in London, Ontario for $55.8 million with $27.1 million of the purchase price being settled in units valued at $11.30 per unit.September 12 – increased the REIT’s unsecured credit facilities from $375 million to $525 million.July 4 – acquired a 141,534 sq

Aug-09-23 10:00AM. NeurAxis Announces Pricing of Initial Public Offering. (GlobeNewswire) NeurAxis, Inc. develops neuromodulation therapies to address chronic and debilitating conditions in children. Its product IB-Stim is a non-surgical device that works by sending gentle electrical impulses into cranial nerve bundles located in the ear.

Nov 15, 2023 · The latest Neuraxis stock prices, stock quotes, news, and NRXS history to help you invest and trade smarter. ... Neuraxis Inc Registered Shs Stock , NRXS. 2.79 +0.39 +16.25% ...

Buy Neuraxis Stock. Neuraxis is a biotechnology business based in the US. Neuraxis shares (NRXS.US) are listed on the NYSE MKT and all prices are listed in US dollars. Its last market close was $3.05 – an increase of 1.67% over the previous day. Neuraxis employs 17 staff and has a trailing 12-month revenue of around $2.5 million.See all brokers. View live Neuraxis, Inc. chart to track its stock's price action. Find market predictions, NRXS financials and market news.According to the issued ratings of 2 analysts in the last year, the consensus rating for NRx Pharmaceuticals stock is Buy based on the current 2 buy ratings for NRXP. The average twelve-month price prediction for NRx Pharmaceuticals is $2.00 with a high price target of $2.00 and a low price target of $2.00. Learn more on NRXP's analyst rating ...Get the latest Brain Scientific Inc (BRSF) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.It now plans to raise $17M by offering 3M shares at a price range of $5 to $6. The company had previously filed to offer the same number of shares at a range of $4 to $6.

NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded on September 18, 2017 and is headquartered in Wilmington, DE. NRXP - NRX Pharmaceuticals Inc ...Stocks To Watch: Conferences And Fedspeak To Dominate Holiday-Shortened Week. Sep. 02, 2023 10:30 AM ET Arm Holdings plc (ARM), SWIN, AESI, NRXS, INTU, RBLX, HUBS, ALGN, ABNB, BX 2 Comments. 8 ...View the latest NRX Pharmaceuticals Inc. (NRXP) stock price, news, historical charts, analyst ratings and financial information from WSJ. Discover historical prices for AAPL stock on Yahoo Finance. View daily, weekly or monthly format back to when Apple Inc. stock was issued.Get the latest Costco Wholesale Corporation (COST) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Nov 30, 2023 · The latest price target for NRX Pharmaceuticals ( NASDAQ: NRXP) was reported by HC Wainwright & Co. on Thursday, May 25, 2023. The analyst firm set a price target for 2.00 expecting NRXP to rise ...

Discover historical prices for AAPL stock on Yahoo Finance. View daily, weekly or monthly format back to when Apple Inc. stock was issued.377,600. *Close price adjusted for splits. **Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Discover historical prices for NRXS stock on Yahoo Finance ... The stock’s 5-day price performance is 0.45%, and it has moved by 19.79% in 30 days. Based on these gigs, the overall price performance for the year is -55.73%. The short interest in SES AI Corporation (NYSE:SES) is 6.5 million shares and it means that shorts have 13.97 day (s) to cover. The consensus price target of analysts on Wall Street ...NeurAxis reports Q3 2023 financial results with a GAAP EPS of -$1.35 and revenue of $0.48M, showing a 22.6% YoY decline.Jul 22, 2021 · What happened. Shares of NRx Pharmaceuticals ( NRXP -5.47%) were trading 70.1% higher as of 11:58 a.m. EDT on Thursday after the company announced that it had validated a formulation for COVID-19 ... 10:10p Mexican magnate’s firm says it can’t pay U.S. bondholders the tens of millions owed ; 10:07p Amazon’s stock reaches a milestone not seen in 19 months

Get the latest news on recent and upcoming IPOs (initial public offerings), pricing and filings for new issues, and today’s top-performing IPO stocks.

Concurrent with the listing, NeurAxis announced the pricing of its underwriter's initial public offering of 1,098,667 shares of common stock at a price of $6 per share.

Despite a brief intra-day dip below its $6 IPO price, shares continue to score bullish interest, closing at or higher than their opening day level in each of its trading sessions. Shares ripped over 10% higher last Friday on the heels of an analyst report from Goldman Smallcap Research that models NRXS shares reaching $14 in the next six to ...Nov 15, 2023 · The latest Neuraxis stock prices, stock quotes, news, and NRXS history to help you invest and trade smarter. ... Neuraxis Inc Registered Shs Stock , NRXS. 2.79 +0.39 +16.25% ... Look back by 650 Calendar Days to analyze a Ticker's Price & Volume across discovered trading dates: What Were Recent Headline News?What Were Price & Volume?...Current and historical p/e ratio for Neuraxis (NRXS) from 2024 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure.CNBC1.37%. $3.03B. META | Complete Meta Platforms Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Real stock prices are not the same as the last traded stock price. Real stock prices are adjustments to closing stock prices. The adjustments are used in a variety of ways, including dividends, the range of prices and the closing price of t...NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded on September 18, 2017 and is headquartered in Wilmington, DE. NRXP - NRX Pharmaceuticals Inc ...Discover historical prices for UPS stock on Yahoo Finance. View daily, weekly or monthly format back to when United Parcel Service, Inc. stock was issued.COIN | Complete Coinbase Global Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

(NYSEMKT: NRXS) Neuraxis stock price per share is $3.27 today (as of Dec 1, 2023). What is Neuraxis's Market Cap? ( NYSEMKT : NRXS ) Neuraxis 's market cap is …What happened. Shares of NRx Pharmaceuticals ( NRXP -5.47%) were trading 70.1% higher as of 11:58 a.m. EDT on Thursday after the company announced that it had validated a formulation for COVID-19 ...According to the issued ratings of 2 analysts in the last year, the consensus rating for NRx Pharmaceuticals stock is Buy based on the current 2 buy ratings for NRXP. The average twelve-month price prediction for NRx Pharmaceuticals is $2.00 with a high price target of $2.00 and a low price target of $2.00. Learn more on NRXP's analyst rating ...15.2%. 10% least volatile stocks in US Market. 2.9%. Stable Share Price: NRXP is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 14% a week. Volatility Over Time: NRXP's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of US stocks.Instagram:https://instagram. nano cap stockscareington care 500 series reviewsdow jones company listinnovations refunds reviews NRx Pharmaceuticals, Inc. (NRXP.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock NRx Pharmaceuticals, Inc. | Nasdaq: NRXP ...$1.71 BANL2.76% U Power Ltd $1.54 UCAR9.41% Market news CNBC schwab international equity etfregional bank index The average price predicted for NRX Pharmaceuticals Inc (NRXP) by analysts is $3.08, which is $2.73 above the current market price. The public float for NRXP is 56.08M, and at present, short sellers hold a 2.74% of that float. On November 30, 2023, the average trading volume of NRXP was 831.50K shares. NRXP) stock’s latest price updateNov 27, 2023 · See the latest Neuraxis Inc stock price (NRXS:XASE), related news, valuation, dividends and more to help you make your investing decisions. best crypto tracking app The average price predicted for NRX Pharmaceuticals Inc (NRXP) by analysts is $3.08, which is $2.73 above the current market price. The public float for NRXP is 56.08M, and at present, short sellers hold a 2.74% of that float. On November 30, 2023, the average trading volume of NRXP was 831.50K shares. NRXP) stock’s latest price …Find the latest Warner Bros. Discovery, Inc. (WBD) stock quote, history, news and other vital information to help you with your stock trading and investing.See the latest Neuraxis Inc stock price (NRXS:XASE), related news, valuation, dividends and more to help you make your investing decisions.